Chronic pain relief: Why Gabapentin may not be a ‘safe’ alternative to opioids

yellow pills x header
Image: Healthline

Gabapentin was supposed to be the answer. Chronic pain afflicts about a fifth of American adults, and for years, doctors thought it could be treated with prescription painkillers like Oxycontin. But as the drugs began killing the equivalent of three planeloads of Americans every week, opioid prescriptions fell off precipitously. Many doctors embraced gabapentin, an anticonvulsant drug traditionally used to prevent seizures, as a way to treat neuropathic pain while avoiding triggering life-threatening addiction.

…

But now their own pitfalls are becoming clear. Though gabapentin and baclofen are much safer alternatives to opioids, recent research suggests that they’re not as safe as some doctors might have hoped.

…

By examining the National Poison Data System, which collects reports of poisonings around the United States, Kimberly Reynolds, a researcher at the University of Pittsburgh, and her co-authors recently found that people are increasingly using both gabapentin and baclofen to either get high or attempt suicide.

…

Reynolds and others say patients who are prescribed drugs like gabapentin and baclofen should be screened for substance-abuse disorders, mood disorders, and suicidal ideation. And patients who are taking gabapentin should avoid mixing it with other drugs, especially depressants such as alcohol and opioids.

Read full, original post: Chronic Pain Is an Impossible Problem

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image Jul 31, 2026, 08_05_37 AM
26% and far worse than during COVID: Under RFK Jr., Americans’ opinion of ‘revamped’ CDC hits an all-time low
Screenshot-2026-10-26-at-11.06.10-AM
Viewpoint: The organic, good-food, small-farm movement is seductive but wrongheaded. Here’s the sustainability and environmental case for industrial farming
Screenshot-2026-10-24-121036
Many hospitals embrace longevity medicine. Are they separating science from hype?
Picture1
Viewpoint: How badly is the U.S. food-safety net fraying? FDA’s bungled handling of the tainted lettuce crisis deepens concerns over cuts to disease tracking and response
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Cancer mRNA Vaccine Concept
'A new frontier': Though scorned by RFK Jr., personalized mRNA vaccine offers hope for many suffering from melanoma skin cancer
China Innovation Lightbulb 2
China’s 5-year plan to accelerate science innovation is putting the U.S. and Europe in the rearview mirror
Screenshot-2026-10-23-at-10.37.12-AM
Viewpoint: Drones, dollars and baby food: Critical innovations that anti-plastic ideologues willfully ignore
Crimson Drips Over the White House
In Trump administration redirect, U.S. steers NIH sharply away from biodefense and pandemic preparedness
Healthy Food Sensitivity Test Collection
Viewpoint: That’ll be $300: The wellness industry’s junk science scam to ‘fix’ your immune system that isn’t broken
West-Virginia-SNAP-Water-Bottle-Sticker
A ‘shining success’ or 'empty promises’: Two years along, West Virginians assess MAHA’s food promises
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.